CHIMERIC THERAPEUTICS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.017 AUD | +6.25% |
|
-5.56% | -51.43% |
| 05-22 | Chimeric Therapeutics' First-in-Human CHM CDH17 Study Opens for Enrollment; Shares Up 4% | MT |
| 05-20 | Chimeric Therapeutics Receives Ethics Approval for CHM CDH17 Phase 1/2 Clinical Trial | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CHIMERIC THERAPEUTICS LIMITED | Bio Therapeutic Drugs | +6.25% | -5.56% | -51.43% | -57.50% | - | 9.2M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- CHM Stock
- Charts Chimeric Therapeutics Limited
- Comparison Chart